316 related articles for article (PubMed ID: 23132731)
1. The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers.
Cohen-Eliav M; Golan-Gerstl R; Siegfried Z; Andersen CL; Thorsen K; Ørntoft TF; Mu D; Karni R
J Pathol; 2013 Mar; 229(4):630-9. PubMed ID: 23132731
[TBL] [Abstract][Full Text] [Related]
2. SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer.
Wan L; Yu W; Shen E; Sun W; Liu Y; Kong J; Wu Y; Han F; Zhang L; Yu T; Zhou Y; Xie S; Xu E; Zhang H; Lai M
Gut; 2019 Jan; 68(1):118-129. PubMed ID: 29114070
[TBL] [Abstract][Full Text] [Related]
3. Zinc-induced modulation of SRSF6 activity alters Bim splicing to promote generation of the most potent apoptotic isoform BimS.
Hara H; Takeda T; Yamamoto N; Furuya K; Hirose K; Kamiya T; Adachi T
FEBS J; 2013 Jul; 280(14):3313-27. PubMed ID: 23648111
[TBL] [Abstract][Full Text] [Related]
4. Splicing factor SRSF6 promotes hyperplasia of sensitized skin.
Jensen MA; Wilkinson JE; Krainer AR
Nat Struct Mol Biol; 2014 Feb; 21(2):189-97. PubMed ID: 24440982
[TBL] [Abstract][Full Text] [Related]
5. Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.
Lal S; Allan A; Markovic D; Walker R; Macartney J; Europe-Finner N; Tyson-Capper A; Grammatopoulos DK
Sci Signal; 2013 Jul; 6(282):ra53. PubMed ID: 23821771
[TBL] [Abstract][Full Text] [Related]
6. Silencing of voltage-gated potassium channel KV9.3 inhibits proliferation in human colon and lung carcinoma cells.
Lee JH; Park JW; Byun JK; Kim HK; Ryu PD; Lee SY; Kim DY
Oncotarget; 2015 Apr; 6(10):8132-43. PubMed ID: 25924237
[TBL] [Abstract][Full Text] [Related]
7. BCLAF1 and its splicing regulator SRSF10 regulate the tumorigenic potential of colon cancer cells.
Zhou X; Li X; Cheng Y; Wu W; Xie Z; Xi Q; Han J; Wu G; Fang J; Feng Y
Nat Commun; 2014 Aug; 5():4581. PubMed ID: 25091051
[TBL] [Abstract][Full Text] [Related]
8. The gene encoding the splicing factor SF2/ASF is a proto-oncogene.
Karni R; de Stanchina E; Lowe SW; Sinha R; Mu D; Krainer AR
Nat Struct Mol Biol; 2007 Mar; 14(3):185-93. PubMed ID: 17310252
[TBL] [Abstract][Full Text] [Related]
9. The oncoprotein SF2/ASF promotes non-small cell lung cancer survival by enhancing survivin expression.
Ezponda T; Pajares MJ; Agorreta J; Echeveste JI; López-Picazo JM; Torre W; Pio R; Montuenga LM
Clin Cancer Res; 2010 Aug; 16(16):4113-25. PubMed ID: 20682707
[TBL] [Abstract][Full Text] [Related]
10. RBM4-Nova1-SRSF6 splicing cascade modulates the development of brown adipocytes.
Lin JC; Chi YL; Peng HY; Lu YH
Biochim Biophys Acta; 2016 Nov; 1859(11):1368-1379. PubMed ID: 27535496
[TBL] [Abstract][Full Text] [Related]
11. The RNA-binding profile of the splicing factor SRSF6 in immortalized human pancreatic β-cells.
Alvelos MI; Brüggemann M; Sutandy FR; Juan-Mateu J; Colli ML; Busch A; Lopes M; Castela Â; Aartsma-Rus A; König J; Zarnack K; Eizirik DL
Life Sci Alliance; 2021 Mar; 4(3):. PubMed ID: 33376132
[TBL] [Abstract][Full Text] [Related]
12. The impact of the RBM4-initiated splicing cascade on modulating the carcinogenic signature of colorectal cancer cells.
Lin JC; Lee YC; Liang YC; Fann YC; Johnson KR; Lin YJ
Sci Rep; 2017 Mar; 7():44204. PubMed ID: 28276498
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic splicing factor SRSF1 is a critical transcriptional target of MYC.
Das S; Anczuków O; Akerman M; Krainer AR
Cell Rep; 2012 Feb; 1(2):110-7. PubMed ID: 22545246
[TBL] [Abstract][Full Text] [Related]
14. The early response to DNA damage can lead to activation of alternative splicing activity resulting in CD44 splice pattern changes.
Filippov V; Filippova M; Duerksen-Hughes PJ
Cancer Res; 2007 Aug; 67(16):7621-30. PubMed ID: 17699766
[TBL] [Abstract][Full Text] [Related]
15. DMP1β, a splice isoform of the tumour suppressor DMP1 locus, induces proliferation and progression of breast cancer.
Maglic D; Stovall DB; Cline JM; Fry EA; Mallakin A; Taneja P; Caudell DL; Willingham MC; Sui G; Inoue K
J Pathol; 2015 May; 236(1):90-102. PubMed ID: 25537728
[TBL] [Abstract][Full Text] [Related]
16. SRSF6 regulates alternative splicing of genes involved in DNA damage response and DNA repair in HeLa cells.
Yang X; Zhan P; Feng S; Ji H; Tian W; Wang M; Cheng C; Song B
Oncol Rep; 2020 Nov; 44(5):1851-1862. PubMed ID: 32901876
[TBL] [Abstract][Full Text] [Related]
17. Identification of alternative splicing events regulated by the oncogenic factor SRSF1 in lung cancer.
de Miguel FJ; Sharma RD; Pajares MJ; Montuenga LM; Rubio A; Pio R
Cancer Res; 2014 Feb; 74(4):1105-15. PubMed ID: 24371231
[TBL] [Abstract][Full Text] [Related]
18. Role of the splicing factor SRSF4 in cisplatin-induced modifications of pre-mRNA splicing and apoptosis.
Gabriel M; Delforge Y; Deward A; Habraken Y; Hennuy B; Piette J; Klinck R; Chabot B; Colige A; Lambert C
BMC Cancer; 2015 Apr; 15():227. PubMed ID: 25884497
[TBL] [Abstract][Full Text] [Related]
19. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
20. AKT-1, -2, and -3 are expressed in both normal and tumor tissues of the lung, breast, prostate, and colon.
Zinda MJ; Johnson MA; Paul JD; Horn C; Konicek BW; Lu ZH; Sandusky G; Thomas JE; Neubauer BL; Lai MT; Graff JR
Clin Cancer Res; 2001 Aug; 7(8):2475-9. PubMed ID: 11489829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
